Resultats de la cerca - Neil Steven

Refinar resultats
  1. 1
    Epstein-Barr virus latency in blood mononuclear cells: analysis of viral gene transcription during primary infection and in the carrier state

    Epstein-Barr virus latency in blood mononuclear cells: analysis of viral gene transcription during primary infection and in the carrier state per Rosemary J. Tierney, Neil Steven, Lawrence S. Young, Alan B. Rickinson

    Publicat 1994
    Obtenir text complet Obtenir text complet
    Artigo
    Afegir a favorits
    Guardat en:
  2. 2
    Epitope focusing in the primary cytotoxic T cell response to Epstein-Barr virus and its relationship to T cell memory.

    Epitope focusing in the primary cytotoxic T cell response to Epstein-Barr virus and its relationship to T cell memory. per Neil Steven, Alison M. Leese, Nicola Annels, S P Lee, Alan B. Rickinson

    Publicat 1996
    Obtenir text complet Obtenir text complet
    Artigo
    Afegir a favorits
    Guardat en:
  3. 3
    Immediate Early and Early Lytic Cycle Proteins Are Frequent Targets of the Epstein-Barr Virus–induced Cytotoxic T Cell Response

    Immediate Early and Early Lytic Cycle Proteins Are Frequent Targets of the Epstein-Barr Virus–induced Cytotoxic T Cell Response per Neil Steven, Nicola Annels, Anita Kumar, Alison M. Leese, Michael G. Kurilla, Alan B. Rickinson

    Publicat 1997
    Obtenir text complet Obtenir text complet
    Artigo
    Afegir a favorits
    Guardat en:
  4. 4
    Beta-hydroxy beta-methylbutyrate/arginine/glutamine (HMB/Arg/Gln) supplementation to improve the management of cachexia in patients with advanced lung cancer: an open-label, multicentre, randomised, controlled phase II trial (NOURISH)

    Beta-hydroxy beta-methylbutyrate/arginine/glutamine (HMB/Arg/Gln) supplementation to improve the management of cachexia in patients with advanced lung cancer: an open-label, multic... per Jennifer Pascoe, Aimee E. Houlton, Charlotte Gaskell, Claire Gaunt, Joyce Thompson, Lucinda Billingham, Neil Steven

    Publicat 2021
    Obtenir text complet Obtenir text complet
    Pré-impressão
    Afegir a favorits
    Guardat en:
  5. 5
    Dual Stimulation of Epstein-Barr Virus (EBV)-Specific CD4<sup>+</sup>- and CD8<sup>+</sup>-T-Cell Responses by a Chimeric Antigen Construct: Potential Therapeutic Vaccine for EBV-Positive Nasopharyngeal Carcinoma

    Dual Stimulation of Epstein-Barr Virus (EBV)-Specific CD4<sup>+</sup>- and CD8<sup>+</sup>-T-Cell Responses by a Chimeric Antigen Construct: Potential Therapeutic Vaccine for EBV-P... per Graham S. Taylor, Tracey A. Haigh, Nancy Gudgeon, R. J. Phelps, S. P. Lee, Neil Steven, Alan B. Rickinson

    Publicat 2003
    Obtenir text complet
    Artigo
    Afegir a favorits
    Guardat en:
  6. 6
    The use of herbal medicines by people with cancer: a qualitative study

    The use of herbal medicines by people with cancer: a qualitative study per Christine Gratus, Sue Wilson, Sheila Greenfield, Sarah Damery, Sally A Warmington, Robert Grieve, Neil Steven, Philip A. Routledge

    Publicat 2009
    Obtenir text complet Obtenir text complet
    Artigo
    Afegir a favorits
    Guardat en:
  7. 7
    Continuous transport of Pacific-derived anthropogenic radionuclides towards the Indian Ocean

    Continuous transport of Pacific-derived anthropogenic radionuclides towards the Indian Ocean per Pittauer, Daniela, Tims, Stephen G., Froehlich, Michaela B., Fifield, L. Keith, Wallner, Anton, McNeil, Steven D., Fischer, Helmut W.

    Publicat 2017
    Obtenir text complet Obtenir text complet Obtenir text complet
    Text
    Afegir a favorits
    Guardat en:
  8. 8
    Retroviral transfer of a dominant TCR prevents surface expression of a large proportion of the endogenous TCR repertoire in human T cells

    Retroviral transfer of a dominant TCR prevents surface expression of a large proportion of the endogenous TCR repertoire in human T cells per D P Hart, Sa Xue, Suzanne Thomas, Michela Cesco-Gaspere, Amy Tranter, Bradley J. Willcox, S. P. Lee, Neil Steven, Emma Morris, H Stauss

    Publicat 2008
    Obtenir text complet
    Artigo
    Afegir a favorits
    Guardat en:
  9. 9
    Infliximab for the treatment of refractory immune-related hepatitis secondary to checkpoint inhibitors: A case report

    Infliximab for the treatment of refractory immune-related hepatitis secondary to checkpoint inhibitors: A case report per Margaret Corrigan, Geoffrey Haydon, Fiona M. Thompson, Neil Rajoriya, Claire L Peplow, Stefan G. Hübscher, Neil Steven, Gideon M. Hirschfield, Matthew J. Armstrong

    Publicat 2019
    Obtenir text complet Obtenir text complet
    Artigo
    Afegir a favorits
    Guardat en:
  10. 10
    Human CD8 + T Cell Responses to EBV EBNA1: HLA Class I Presentation of the (Gly-Ala)–Containing Protein Requires Exogenous Processing

    Human CD8 + T Cell Responses to EBV EBNA1: HLA Class I Presentation of the (Gly-Ala)–Containing Protein Requires Exogenous Processing per Neil Blake, Steven Lee, Irina Redchenko, Wendy Thomas, Neil Steven, Alison M. Leese, Patty Steigerwald-Mullen, Michael G. Kurilla, Lori Frappier, Alan B. Rickinson

    Publicat 1997
    Obtenir text complet Obtenir text complet
    Artigo
    Afegir a favorits
    Guardat en:
  11. 11
    Direct Visualization of Antigen-specific CD8+T Cells during the Primary Immune Response to Epstein-Barr Virus In Vivo

    Direct Visualization of Antigen-specific CD8+T Cells during the Primary Immune Response to Epstein-Barr Virus In Vivo per Margaret Callan, Linda Tan, N. E. Annels, Graham S. Ogg, Jamie Wilson, Christopher A. O’Callaghan, Neil Steven, Andrew J. McMichael, A. B. Rickinson

    Publicat 1998
    Obtenir text complet Obtenir text complet
    Artigo
    Afegir a favorits
    Guardat en:
  12. 12
    Vaccination of colorectal cancer patients with TroVax given alongside chemotherapy (5-fluorouracil, leukovorin and irinotecan) is safe and induces potent immune responses

    Vaccination of colorectal cancer patients with TroVax given alongside chemotherapy (5-fluorouracil, leukovorin and irinotecan) is safe and induces potent immune responses per Richard Harrop, Noel Drury, William Shingler, P. Chikoti, Irina Redchenko, Miles W. Carroll, Susan M. Kingsman, Stuart Naylor, Richard W. Griffiths, Neil Steven, Robert E. Hawkins

    Publicat 2007
    Obtenir text complet Obtenir text complet
    Artigo
    Afegir a favorits
    Guardat en:
  13. 13
    Antibacterial Prophylaxis after Chemotherapy for Solid Tumors and Lymphomas

    Antibacterial Prophylaxis after Chemotherapy for Solid Tumors and Lymphomas per Michael Cullen, Neil Steven, Lucinda Billingham, Claire Gaunt, Mark Hastings, Peter Simmonds, Nicholas Stuart, Daniel Rea, Mark Bower, Indrajit Fernando, Robert Huddart, Simon Gollins, Andrew Stanley

    Publicat 2005
    Obtenir text complet Obtenir text complet
    Artigo
    Afegir a favorits
    Guardat en:
  14. 14
    Merkel Cell Polyomavirus Small T Antigen Mediates Microtubule Destabilization To Promote Cell Motility and Migration

    Merkel Cell Polyomavirus Small T Antigen Mediates Microtubule Destabilization To Promote Cell Motility and Migration per Laura M. Knight, Gabrielė Stakaitytė, J. Wood Jennifer, Hussein Abdul-Sada, David Griffiths, Gareth Howell, Rachel Wheat, G. Eric Blair, Neil Steven, Andrew Macdonald, David J. Blackbourn, Adrian Whitehouse

    Publicat 2014
    Obtenir text complet Obtenir text complet
    Artigo
    Afegir a favorits
    Guardat en:
  15. 15
    Patient-reported outcomes in KEYNOTE-006, a randomised study of pembrolizumab versus ipilimumab in patients with advanced melanoma

    Patient-reported outcomes in KEYNOTE-006, a randomised study of pembrolizumab versus ipilimumab in patients with advanced melanoma per Teresa M. Petrella, Caroline Robert, Erika Richtig, Wilson H. Miller, Giuseppe Masucci, Euan Walpole, Célèste Lebbé, Neil Steven, Mark R. Middleton, Darcy A. Hille, Wei Zhou, Nageatte Ibrahim, Jonathan Cebon

    Publicat 2017
    Obtenir text complet
    Artigo
    Afegir a favorits
    Guardat en:
  16. 16
    Seronegative antibody‐mediated neurology after immune checkpoint inhibitors

    Seronegative antibody‐mediated neurology after immune checkpoint inhibitors per R. Wilson, David A. Menassa, Alexander J. Davies, Sophia Michael, Joanna Hester, Wilhelm Küker, Graham P. Collins, Judith Cossins, David Beeson, Neil Steven, Paul Maddison, Simon Rinaldi, Saiju Jacob, Sarosh R. Irani

    Publicat 2018
    Obtenir text complet Obtenir text complet
    Artigo
    Afegir a favorits
    Guardat en:
  17. 17
    Phase I Trial of Recombinant Modified Vaccinia Ankara Encoding Epstein–Barr Viral Tumor Antigens in Nasopharyngeal Carcinoma Patients

    Phase I Trial of Recombinant Modified Vaccinia Ankara Encoding Epstein–Barr Viral Tumor Antigens in Nasopharyngeal Carcinoma Patients per Edwin P. Hui, Graham S. Taylor, Hui Jia, Brigette Ma, Stephen L. Chan, Rosalie Ho, Wai-Lap Wong, Steven Ray Wilson, Benjamin F. Johnson, Ceri Edwards, Deborah Stocken, Alan B. Rickinson, Neil Steven, Anthony T.�C. Chan

    Publicat 2013
    Obtenir text complet Obtenir text complet
    Artigo
    Afegir a favorits
    Guardat en:
  18. 18
    A phase I/II and pharmacokinetic study of irinotecan in combination with capecitabine as first-line therapy for advanced colorectal cancer

    A phase I/II and pharmacokinetic study of irinotecan in combination with capecitabine as first-line therapy for advanced colorectal cancer per D. Rea, J. W. R. Nortier, W.W. ten Bokkel Huinink, Stephen Falk, Dick J. Richel, Tim Maughan, Gerard Groenewegen, Jeff M. Smit, Neil Steven, J.M. Bakker, Dorothée Sémiond, Rachel Kerr, Cornelis J.A. Punt

    Publicat 2005
    Obtenir text complet Obtenir text complet
    Artigo
    Afegir a favorits
    Guardat en:
  19. 19
    A Phase I Trial of Epstein-Barr Virus Gp350 Vaccine for Children With Chronic Kidney Disease Awaiting Transplantation

    A Phase I Trial of Epstein-Barr Virus Gp350 Vaccine for Children With Chronic Kidney Disease Awaiting Transplantation per Lesley Rees, E. Jane Tizard, Andrew Morgan, W. D. Cubitt, S. Finerty, T Oyewole-Eletu, Karen Owen, Collin Royed, Servi J.C. Stevens, Rukshana Shroff, Manjit Tanday, A.D. Wilson, Jaap M. Middeldorp, P L Amlot, Neil Steven

    Publicat 2009
    Obtenir text complet
    Artigo
    Afegir a favorits
    Guardat en:
  20. 20
    Clinical and Biological Effects of an Agonist Anti-CD40 Antibody: A Cancer Research UK Phase I Study

    Clinical and Biological Effects of an Agonist Anti-CD40 Antibody: A Cancer Research UK Phase I Study per Peter Johnson, Ruth Challis, Ferdousi Chowdhury, Yifang Gao, Melanie Harvey, T. Geldart, Paul Kerr, H. T. Claude Chan, Anna R. Smith, Neil Steven, Ceri Edwards, Margaret Ashton‐Key, E. Hodges, Andrew Tutt, Christian H. Ottensmeier, Martin J. Glennie, Anthony P. Williams

    Publicat 2015
    Obtenir text complet Obtenir text complet
    Artigo
    Afegir a favorits
    Guardat en:

Eines de cerca: